Supplier · Peer benchmark
Peer comparison
How IPS Pharma stacks up against suppliers competing for the same workloads — based on overlap with its 5 signature CPV codes over the last 24 months.
Value band:
/
CohortIPS Pharma(You)Dennis Eagle LimitedBMG RESEARCH LTDGXOLand Recovery Rail LtdViaVan
iAuto-picked from 5 signature CPV codes · last 24 months overlap
Metric | DE Dennis Eagle Limited Peer · rank #1 | BR BMG RESEARCH LTD Peer · rank #2 | IP IPS Pharma (You) · target supplier | GX GXO Peer · rank #4 | LR Land Recovery Rail Ltd Peer · rank #5 | VI ViaVan Peer · rank #6 |
|---|---|---|---|---|---|---|
01ActivityVolume, scale, freshness | ||||||
| 12-month contractedAward value, last 12m | £83.6m | £1.7m | — | — | — | — |
| Framework headroomPer-supplier share of framework ceilings | — | — | — | — | — | — |
| Total awarded (lifetime)All time, all contracts | £829.5m | £30.8m | £233k(−99%) | £4.2bn | £5.5m | £5.5m |
| Contracts won (12m)Distinct awards last year | 44 | 13 | — | — | — | |
How to read a target cell
The target column carries a delta — value compared to the peer median for that row. Direction-of-good varies by metric, so deltas are neutral.
Peer cell£499m(peer median £255m)
→
Target cell£11.7m(−97% vs median)
Money:
£N.Nm, £Nk, £N.NbnPercent: 42% · pp delta: (+12pp)Day delta: (−149 days) · missing: —